▶ 調査レポート

世界の重症筋無力症治療市場予測(~2024年)

• 英文タイトル:Global Myasthenia Gravis Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の重症筋無力症治療市場予測(~2024年) / Global Myasthenia Gravis Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR09D4153資料のイメージです。• レポートコード:B-GIR09D4153
• 出版社/出版日:GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、重症筋無力症治療の世界市場について調べ、まとめました。種類別セグメントは、重症筋無力症、先天性筋無力症、一般化筋無力症、一過性筋無力症、その他等、用途別セグメントは、病院及び診療所、診断センター、学術研究機関等に区分しました。重症筋無力症治療の世界市場概観、企業動向、企業別重症筋無力症治療シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・重症筋無力症治療の市場概観
・重症筋無力症治療の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・重症筋無力症治療の企業別販売動向、市場シェア、市場集中度、競争動向
・重症筋無力症治療の世界市場規模
・重症筋無力症治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・重症筋無力症治療のアメリカ市場規模推移
・重症筋無力症治療のカナダ市場規模推移
・重症筋無力症治療のメキシコ市場規模推移
・重症筋無力症治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・重症筋無力症治療のドイツ市場規模推移
・重症筋無力症治療のイギリス市場規模推移
・重症筋無力症治療のロシア市場規模推移
・重症筋無力症治療のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・重症筋無力症治療の日本市場規模推移
・重症筋無力症治療の中国市場規模推移
・重症筋無力症治療の韓国市場規模推移
・重症筋無力症治療のインド市場規模推移
・重症筋無力症治療の東南アジア市場規模推移
・重症筋無力症治療の南米市場分析(ブラジル、アルゼンチン等)
・重症筋無力症治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・重症筋無力症治療の種類別分析/販売量、売上、市場シェア(重症筋無力症、先天性筋無力症、一般化筋無力症、一過性筋無力症、その他)
・重症筋無力症治療の用途別分析/市場規模(病院及び診療所、診断センター、学術研究機関)
・重症筋無力症治療の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・重症筋無力症治療の販売チャネル・代理店・貿易業者・ディーラー分析

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs.

Scope of the Report:
The global Myasthenia Gravis Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Myasthenia Gravis Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Myasthenia Gravis Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Myasthenia Gravis Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers
Alexion Pharmaceuticals
Novartis
CSL Behring
Grifols

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Ocular Myasthenia Gravis
Congenital Myasthenia Gravis
Generalized Myasthenia Gravis
Transient Myasthenia Gravis
Others

Market Segment by Applications, can be divided into
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations

レポート目次

Table of Contents

1 Myasthenia Gravis Therapies Market Overview
1.1 Product Overview and Scope of Myasthenia Gravis Therapies
1.2 Classification of Myasthenia Gravis Therapies by Types
1.2.1 Global Myasthenia Gravis Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Myasthenia Gravis Therapies Revenue Market Share by Types in 2018
1.2.3 Ocular Myasthenia Gravis
1.2.4 Congenital Myasthenia Gravis
1.2.5 Generalized Myasthenia Gravis
1.2.6 Transient Myasthenia Gravis
1.2.7 Others
1.3 Global Myasthenia Gravis Therapies Market by Application
1.3.1 Global Myasthenia Gravis Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Global Myasthenia Gravis Therapies Market by Regions
1.4.1 Global Myasthenia Gravis Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Myasthenia Gravis Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Myasthenia Gravis Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Myasthenia Gravis Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Myasthenia Gravis Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Myasthenia Gravis Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Myasthenia Gravis Therapies (2014-2024)
2 Manufacturers Profiles
2.1 Alexion Pharmaceuticals
2.1.1 Business Overview
2.1.2 Myasthenia Gravis Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alexion Pharmaceuticals Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Myasthenia Gravis Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL Behring
2.3.1 Business Overview
2.3.2 Myasthenia Gravis Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Behring Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 Grifols
2.4.1 Business Overview
2.4.2 Myasthenia Gravis Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Grifols Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Myasthenia Gravis Therapies Market Competition, by Players
3.1 Global Myasthenia Gravis Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Myasthenia Gravis Therapies Players Market Share
3.2.2 Top 10 Myasthenia Gravis Therapies Players Market Share
3.3 Market Competition Trend
4 Global Myasthenia Gravis Therapies Market Size by Regions
4.1 Global Myasthenia Gravis Therapies Revenue and Market Share by Regions
4.2 North America Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
5 North America Myasthenia Gravis Therapies Revenue by Countries
5.1 North America Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
5.2 USA Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
6 Europe Myasthenia Gravis Therapies Revenue by Countries
6.1 Europe Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
6.2 Germany Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
6.4 France Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Myasthenia Gravis Therapies Revenue by Countries
7.1 Asia-Pacific Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
7.2 China Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
7.5 India Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
8 South America Myasthenia Gravis Therapies Revenue by Countries
8.1 South America Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
8.2 Brazil Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Myasthenia Gravis Therapies by Countries
9.1 Middle East and Africa Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
10 Global Myasthenia Gravis Therapies Market Segment by Type
10.1 Global Myasthenia Gravis Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Myasthenia Gravis Therapies Market Forecast by Type (2019-2024)
10.3 Ocular Myasthenia Gravis Revenue Growth Rate (2014-2024)
10.4 Congenital Myasthenia Gravis Revenue Growth Rate (2014-2024)
10.5 Generalized Myasthenia Gravis Revenue Growth Rate (2014-2024)
10.6 Transient Myasthenia Gravis Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Myasthenia Gravis Therapies Market Segment by Application
11.1 Global Myasthenia Gravis Therapies Revenue Market Share by Application (2014-2019)
11.2 Myasthenia Gravis Therapies Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2014-2019)
11.4 Diagnostic Centers Revenue Growth (2014-2019)
11.5 Academic and Research Organizations Revenue Growth (2014-2019)
12 Global Myasthenia Gravis Therapies Market Size Forecast (2019-2024)
12.1 Global Myasthenia Gravis Therapies Market Size Forecast (2019-2024)
12.2 Global Myasthenia Gravis Therapies Market Forecast by Regions (2019-2024)
12.3 North America Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
12.6 South America Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Myasthenia Gravis Therapies Picture
Table Product Specifications of Myasthenia Gravis Therapies
Table Global Myasthenia Gravis Therapies and Revenue (Million USD) Market Split by Product Type
Figure Global Myasthenia Gravis Therapies Revenue Market Share by Types in 2018
Figure Ocular Myasthenia Gravis Picture
Figure Congenital Myasthenia Gravis Picture
Figure Generalized Myasthenia Gravis Picture
Figure Transient Myasthenia Gravis Picture
Figure Others Picture
Table Global Myasthenia Gravis Therapies Revenue (Million USD) by Application (2014-2024)
Figure Myasthenia Gravis Therapies Revenue Market Share by Applications in 2018
Figure Hospitals and Clinics Picture
Figure Diagnostic Centers Picture
Figure Academic and Research Organizations Picture
Table Global Market Myasthenia Gravis Therapies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals Myasthenia Gravis Therapies Type and Applications
Table Alexion Pharmaceuticals Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Myasthenia Gravis Therapies Type and Applications
Table Novartis Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Myasthenia Gravis Therapies Type and Applications
Table CSL Behring Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Myasthenia Gravis Therapies Type and Applications
Table Grifols Myasthenia Gravis Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Myasthenia Gravis Therapies Revenue (Million USD) by Players (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue Share by Players (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Share by Players in 2017
Figure Global Myasthenia Gravis Therapies Revenue Share by Players in 2018
Figure Global Top 5 Players Myasthenia Gravis Therapies Revenue Market Share in 2018
Figure Global Top 10 Players Myasthenia Gravis Therapies Revenue Market Share in 2018
Figure Global Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue (Million USD) by Regions (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Market Share by Regions in 2018
Figure North America Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Europe Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure South America Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Table North America Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
Table North America Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Myasthenia Gravis Therapies Revenue Market Share by Countries in 2018
Figure USA Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Canada Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Mexico Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Table Europe Myasthenia Gravis Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure Europe Myasthenia Gravis Therapies Revenue Market Share by Countries in 2018
Figure Germany Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure UK Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure France Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Russia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Italy Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Myasthenia Gravis Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Myasthenia Gravis Therapies Revenue Market Share by Countries in 2018
Figure China Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Japan Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Korea Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure India Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Table South America Myasthenia Gravis Therapies Revenue by Countries (2014-2019)
Table South America Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Myasthenia Gravis Therapies Revenue Market Share by Countries in 2018
Figure Brazil Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Argentina Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Colombia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Myasthenia Gravis Therapies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Myasthenia Gravis Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Myasthenia Gravis Therapies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure UAE Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Egypt Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure Nigeria Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Figure South Africa Myasthenia Gravis Therapies Revenue and Growth Rate (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue (Million USD) by Type (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue Share by Type (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Share by Type (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Share by Type in 2019
Table Global Myasthenia Gravis Therapies Revenue Forecast by Type (2019-2024)
Figure Global Myasthenia Gravis Therapies Market Share Forecast by Type (2019-2024)
Figure Global Ocular Myasthenia Gravis Revenue Growth Rate (2014-2019)
Figure Global Congenital Myasthenia Gravis Revenue Growth Rate (2014-2019)
Figure Global Generalized Myasthenia Gravis Revenue Growth Rate (2014-2019)
Figure Global Transient Myasthenia Gravis Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue by Application (2014-2019)
Table Global Myasthenia Gravis Therapies Revenue Share by Application (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Share by Application (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Share by Application in 2019
Table Global Myasthenia Gravis Therapies Revenue Forecast by Application (2019-2024)
Figure Global Myasthenia Gravis Therapies Market Share Forecast by Application (2019-2024)
Figure Global Hospitals and Clinics Revenue Growth Rate (2014-2019)
Figure Global Diagnostic Centers Revenue Growth Rate (2014-2019)
Figure Global Academic and Research Organizations Revenue Growth Rate (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Myasthenia Gravis Therapies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Myasthenia Gravis Therapies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
Figure Europe Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
Figure South America Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Myasthenia Gravis Therapies Revenue Market Forecast (2019-2024)